Lexeo Therapeutics (LXEO) & Its Peers Head-To-Head Survey
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) is one of 287 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its rivals? We will compare Lexeo Therapeutics to related businesses based on the strength of its profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation. Analyst Recommendations This […]
More Stories
Bank of America Co. (NYSE:BAC) Major Shareholder Sells $154,725,779.52 in Stock
Bank of America Co. (NYSE:BAC) major shareholder Berkshire Hathaway Inc sold 3,915,126 shares of the stock in a transaction on...
Insider Selling: Royal Bank of Canada (TSE:RY) Senior Officer Sells C$2,855,150.00 in Stock
Royal Bank of Canada (TSE:RY – Get Free Report) (NYSE:RY) Senior Officer Douglas Antony Guzman sold 17,000 shares of the...
Insider Selling: Toll Brothers, Inc. (NYSE:TOL) CEO Sells 50,000 Shares of Stock
Toll Brothers, Inc. (NYSE:TOL – Get Free Report) CEO Douglas C. Jr. Yearley sold 50,000 shares of Toll Brothers stock...
Janux Therapeutics, Inc. (NASDAQ:JANX) Insider Sells $2,298,000.00 in Stock
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) insider Andrew Hollman Meyer sold 50,000 shares of the stock in a...
Critical Analysis: Amazon.com (NASDAQ:AMZN) & Beyond (NYSE:BYON)
Amazon.com (NASDAQ:AMZN – Get Free Report) and Beyond (NYSE:BYON – Get Free Report) are both retail/wholesale companies, but which is...
Short Interest in U.S. Global Investors, Inc. (NASDAQ:GROW) Rises By 24.6%
U.S. Global Investors, Inc. (NASDAQ:GROW – Get Free Report) saw a large growth in short interest in September. As of...